Clinical Trial Update: Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement [NA]

View source ↗

Summary

Safety and efficacy data from a continued access study of the Medtronic CoreValve System in high and very high risk patients with symptomatic severe aortic sten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• CoreValve System

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Severe Aortic Stenosis | NA | Status: COMPLETED | Results posted: 2017-07-18